11:00 AM EDT, 03/17/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, rising 1.12% to 1,433.84 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by pharmaceutical company Ascendis Pharma ( ASND ) and medical device maker EDAP TMS ( EDAP ) , which climbed 7.6% and 6%, respectively. They were followed by pharmaceutical company Novo Nordisk ( NVO ) and semiconductor company Sequans Communications ( SQNS ) , which rose 3.3% and 2.9%, respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis ( CLLS ) and internet advertising firm Criteo ( CRTO ) , which dropped 2.8% and 1.8%, respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and accommodations booking site trivago (TRVG), which were down 1.7% and 0.5%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma ( VRNA ) and cruise line operator Carnival (CUK), which advanced 5.9% and 3.1%, respectively. They were followed by software firm Endava ( DAVA ) and insurance company Prudential (PUK), which were up 3.2% and 1.9%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and biotech firm Trinity Biotech ( TRIB ) , which lost 5.9% and 4.1%, respectively. They were followed by biopharmaceutical companies Amarin ( AMRN ) and Akari Therapeutics ( AKTX ) , which fell 2.7% and 1.8%, respectively.